Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

NCT03923920 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03923920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03923920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Systemic Amyloidosis Via the Ligamentum Flavum
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Completed
Start date
May 1, 2019
Completion date
December 2, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloid, amyloidosis, primary amyloidosis of light chain type, spinal stenosis, transthyretin amyloidosis